Sanjiv Sam Gambhir, MD, PhD
18 F-fluoride PET/CT versus 99Tc-MDP Scanning for Detecting Bone Metastases
Contact Information
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Brief
To compare the accuracy of regular bone scanning to that of 18F PET/CT canning for detecting cancer that has spread to the bone (bone metastasis).
Recruiting Status:
RecruitingStanford Recruiting Status:
RecruitingCondition(s):
Intervention(s):
Phase:
N/AEligibility
Ages Eligible for Study:
18 years to Any AgeGenders Eligible for Study:
Male and FemaleHealth of Volunteers:
People with the conditions listed in this trial can participate as controls.Key Inclusion Criteria:
Patients with newly diagnosed >= stage 3 breast cancer, >= stage III lung cancer and >= stage 2 prostate cancer and/or PSA >10 micrograms/L. This also includes patients with recurrent breast, lung and prostate cancer.
- Consecutive patients who are scheduled to undergo a conventional planar bone scan
- Patient may have had a prior PET or PET/CT scan for staging/restaging.
- Patient must be able to tolerate PET/CT (i.e., not claustrophobic and able to lie supine for 1 hour).
Determination of eligibility
The eligibility will be based solely on the clinical basis of >= stage 3 breast cancer, >= stage III lung cancer and >= stage 2 prostate cancer and/or PSA >10 micrograms/L as determined by the referring physician.
Key Exclusion Criteria:
- Patient < 18 years of age.
- Pregnant patients. (This is in order to avoid unnecessary radiation exposure. A pregnancy tests must be done in every women of child bearing age.)
- Patients who are cognitively unable to provide informed consent.
Additional Study Details
Official Title:
18 F-fluoride PET/CT versus 99Tc-MDP Scanning for Detecting Bone Metastases: A Randomized Multi-Center-TrialAnticipated start date:
3/31/2009Lead Sponsor:
Academy of Molecular ImagingCollaborator(s):
- UCLA
- MSKCC
- Greater LA VA
- MD Anderson
- Cedars Sinai Medical Center
- Washington University
- Duke
- Dartmouth
- St Louis University
- Scottsdale Medical Imaging
Investigator(s):
Study Type:
ObservationalPurpose:
NOTNEEDEDDuration:
LongitudinalSelection:
Defined PopulationTiming:
ProspectiveTotal Number to be Enrolled:
300Total Number to be Enrolled at Stanford:
30More Information
Secondary ID(s):
- BONE0002
Locations & Contacts
Stanford Locations & Contacts:
Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305Non-Stanford Locations:
The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.
This listing was last updated:
3/20/2009PLEASE NOTE:
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.
Help